NEW YORK (Reuters Health) – A long-term analysis of the IMvigor211 clinical trial shows that…
View More Longer-Term Analysis Finds Survival Benefit of Atezolizumab in Metastatic Bladder CancerHome »
Study: Targeted therapy prolongs survival in patients with advanced bladder cancer
In a new study led by researchers at Yale Cancer Center (YCC), the drug enfortumab…
View More Study: Targeted therapy prolongs survival in patients with advanced bladder cancerVexazone
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VEXAZONE contains…
View More Vexazone